People · Operator
Named in public records as an officer, director or promoter · active 2009–2022 · Other Technology, Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mirantis, Inc. | — | Other Technology | Series C | $152.8M | $23.2M | 2016 |
| Exagen Diagnostics Inc | — | Biotechnology | Series B | $88.5M | $261.4M | 2009 |
| Signature Resources Ltd. | — | Other | Pre-Seed | $2.2M | $4.8M | 2022 |
Lisa Davis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Lisa Davis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Blivin | 1 | 14 |
| Dinesh Patel | 1 | 13 |
| Dharmesh Thakker | 1 | 11 |
| Jeff Horing | 1 | 11 |
| Scott L. Glenn | 1 | 9 |
| Brian Birk | 1 | 8 |
| James L.L. Tullis | 1 | 6 |
| John Hayes | 1 | 5 |
| Scott Glenn | 1 | 4 |
| Waneta C. Tuttle | 1 | 4 |
| Jonathan Held | 1 | 4 |
| Andrew Fligel | 1 | 3 |
| Daniel C. Burrell | 1 | 3 |
| Praveen Akkiraju | 1 | 3 |
| Elise Huang | 1 | 2 |
| Michael R. Walsh | 1 | 2 |
| John Bessone | 1 | 2 |
| Rene Bonvanie | 1 | 2 |
| Michael J. Walsh | 1 | 2 |
| Curt R. LaBelle | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.